@article{3e39b636a2df4a759db6d4aacab7f02e,
title = "Interassociation consensus statement on cardiovascular care of college student-athletes",
abstract = "Cardiovascular evaluation and care of college student-athletes is gaining increasing attention from both the public and medical communities. Emerging strategies include screening of the general athlete population, recommendations of permissible levels of participation by athletes with identified cardiovascular conditions, and preparation for responding to unanticipated cardiac events in athletic venues. The primary focus has been sudden cardiac death and the utility of screening with or without advanced cardiac screening. The National Collegiate Athletic Association convened a multidisciplinary task force to address cardiovascular concerns in collegiate student-athletes and to develop consensus for an interassociation statement. This document summarizes the task force deliberations and follow-up discussions, and includes available evidence on cardiovascular risk, pre-participation evaluation, and the recognition of and response to cardiac arrest. Future recommendations for cardiac research initiatives, education, and collaboration are also provided. (J Am Coll Cardiol 2016;doi: 10.1016/j.jacc.2016.03.527.) {\'O}2016 by the American College of Cardiology Foundation.",
keywords = "Cardiac arrest, Electrocardiogram, Emergency action plan, Pre-participation screening, Studentathlete, Sudden cardiac death",
author = "Brian Hainline and Jonathan Drezner and Aaron Baggish and Harmon, {Kimberly G.} and Emery, {Michael S.} and Myerburg, {Robert J.} and Eduardo Sanchez and Silvana Molossi and Parsons, {John T.} and Thompson, {Paul D.}",
note = "Funding Information: Funding for the multidisciplinary task force, held at the National Collegiate Athletic Association (NCAA) headquarters in September 2014, was provided by the NCAA Sport Science Institute. The task force included representatives from the following affiliations: American Academy of Pediatrics{\textquoteright} Council on Sports Medicine and Physical Fitness; National Athletic Trainers{\textquoteright} Association; College Athletic Trainers{\textquoteright} Society; American Medical Society for Sports Medicine; American College of Cardiology Sports and Exercise Cardiology Leadership Council; National Federation of State High School Associations; American Orthopaedic Society for Sports Medicine; NCAA Student-Athlete Advisory Council; American Osteopathic Academy of Sports Medicine, National Strength and Conditioning Association; Collegiate Strength and Conditioning Coaches Association; American Heart Association; NCAA Committee on Competitive Safeguards and Medical Aspects of Sports; and the American College of Sports Medicine. Dr. Thompson has received research support from Genomas, Roche, Sanofi, Regeneron, Esperion, Amarin, and Pfizer; has served as a consultant for Amgen, Regeneron, Merck, Esperion, and Sanofi; has received speaker honoraria from Merck, AstraZeneca, Regeneron, Sanofi, and Amgen; owns stock in AbbVie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, and JA Willey; and has provided expert legal testimony on exercise-related cardiac events and statin myopathy. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Publisher Copyright: {\textcopyright} by the National Athletic Trainers? Association, Inc. Copyright: Copyright 2016 Elsevier B.V., All rights reserved.",
year = "2016",
month = apr,
doi = "10.4085/j.jacc.2016.03.527",
language = "English (US)",
volume = "51",
pages = "344--357",
journal = "Journal of Athletic Training",
issn = "1062-6050",
publisher = "National Athletic Trainers' Association Inc.",
number = "4",
}